BlueRock Therapeutics
Executives
View the org chart displaying its 16 main executives
Most searched biographies at BlueRock Therapeutics
- Seth Ettenberg, Director, President and Chief Executive Officer
- Emile Nuwaysir, Chairman of the Board
- Stefan Oelrich, Director
Create your alert
to follow the executive moves at BlueRock Therapeutics.
Biotechnology
BlueRock Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by BlueRock Therapeutics
- News - BlueRock Therapeutics LP
- BlueRock Therapeutics Announces New Board Chair, New President and CEO - Engineered Cell TherapyBlueRock Therapeutics Announces New Board Chair, New President and CEO - Engineered Cell Therapy
- BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease - Engineered Cell TherapyBlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Diseas
- BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson's Disease - Engineered Cell TherapyBlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced
- Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine - Engineered Cell TherapySenti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Th
- BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases - Engineered Cell TherapyBlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis The
- BlueRock Therapeutics Receives Permission from Health Canada for DA01 Trial in Parkinson's Disease - Engineered Cell TherapyBlueRock Therapeutics Receives Permission from Health Canada for DA01 Trial in Parkinson's Disease - Engineered Cell Therapy
- BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND Clearance for DA01 in Parkinson's Disease - Engineered Cell Therapy
- BlueRock Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa
- BlueRock Therapeutics President and CEO Emile Nuwaysir elected to serve as Vice Chairman of the Alliance for Regenerative Medicine
- View more press releases Close
Social media about BlueRock Therapeutics
- BlueRock Therapeutics on Wikipedia, Google News & Yahoo Finance
- BlueRock Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Seth Ettenberg 
Call BlueRock Therapeutics at +1 415...
